

HY-141512 · 5 mg
MedChemExpress · Cat: HY-141512
Reach 3+ verified distributors
Manufacturer product page
medchemexpress.com/jb170.html
Description
JB170 is a potent and highly specific PROTAC-mediated AURORA-A Aurora Kinase degrader DC50=28 nM by linking Alisertib, to the Cereblon-binding molecule Thalidomide. JB170 preferentially binds AURORA-A EC50=193 nM over AURORA-B EC50=1.4 AAasAasAAmuM . JB170-mediated S-phase arrest is caused specifically by AURORA-A depletion. JB170 has excellent ability to inhibit non-catalytic function of AURORA-A kinase.





